查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1318013

瘧疾疫苗市場：按類型、藥物、最終用戶分類 - 全球預測 2023-2030

Malaria Vaccine Market by Type, Agent, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球瘧疾疫苗市場預計到2023年將達到6,434萬美元，年複合成長率為25.77%，預計到2030年將出現驚人成長，達到3,2066萬美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球瘧疾疫苗市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 瘧疾疫苗的全球市場規模和預測是多少？

2.在預測期內，COVID-19 對全球瘧疾疫苗市場的阻礙因素和影響為何？

3. 在預測期內，全球瘧疾疫苗市場需要投資哪些產品/細分市場/應用/領域？

4.全球瘧疾疫苗市場的競爭策略是什麼？

5. 全球瘧疾疫苗市場的技術趨勢和法律規範是什麼？

6. 全球瘧疾疫苗市場主要供應商的市佔率是多少？

7. 哪些型態和策略性措施被認為適合進入全球瘧疾疫苗市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 增加常規免疫計劃
      • 瘧疾疫苗的供應、可近性的提高和政府的有利支持
      • 提高患者對瘧疾的認知和發病率
    • 抑制因素
      • 疫苗很貴
    • 機會
      • 新佐劑的不斷出現和突破性的疫苗傳遞方案
      • 製藥業疫苗開發的進展
    • 任務
      • 嚴格法規場景
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 瘧疾疫苗市場：依類型

  • 紅血球疫苗
  • 多重抗原疫苗
  • 紅血球前疫苗

第7章 瘧疾疫苗市場（依代理商）

  • 按蚊種
  • 惡性瘧原蟲
  • 間日瘧原蟲

第8章 瘧疾疫苗市場：依最終用戶分類

  • 診所
  • 社區中心
  • 醫院

第9章 美洲瘧疾疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區瘧疾疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲瘧疾疫苗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-035DA3C63711

The Global Malaria Vaccine Market is forecasted to grow significantly, with a projected USD 64.34 million in 2023 at a CAGR of 25.77% and expected to reach a staggering USD 320.66 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Malaria Vaccine Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Malaria Vaccine Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Erythrocytic Vaccine, Multi-Antigen Vaccine, and Pre-Erythrocytic Vaccine. The Erythrocytic Vaccine is projected to witness significant market share during forecast period.

Based on Agent, market is studied across Anopheles Species, Plasmodium Falciparum, and Plasmodium Vivax. The Anopheles Species is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Clinics, Community Centers, and Hospitals. The Community Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Malaria Vaccine Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Malaria Vaccine Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Malaria Vaccine Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Malaria Vaccine Market?

4. What is the competitive strategic window for opportunities in the Global Malaria Vaccine Market?

5. What are the technology trends and regulatory frameworks in the Global Malaria Vaccine Market?

6. What is the market share of the leading vendors in the Global Malaria Vaccine Market?

7. What modes and strategic moves are considered suitable for entering the Global Malaria Vaccine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Malaria Vaccine Market, by Type, 2022 vs 2030
  • 4.3. Malaria Vaccine Market, by Agent, 2022 vs 2030
  • 4.4. Malaria Vaccine Market, by End-User, 2022 vs 2030
  • 4.5. Malaria Vaccine Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Proliferation in the number of routine immunizations programs
      • 5.1.1.2. Rising availability, accessibility and favorable government support for malaria vaccine
      • 5.1.1.3. Growing patient awareness and incidence of malaria
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advent of novel adjuvants and breakthrough vaccine delivery programs
      • 5.1.3.2. Rising advancements in pharmaceutical industry for vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Rigid regulative scenarios
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Malaria Vaccine Market, by Type

  • 6.1. Introduction
  • 6.2. Erythrocytic Vaccine
  • 6.3. Multi-Antigen Vaccine
  • 6.4. Pre-Erythrocytic Vaccine

7. Malaria Vaccine Market, by Agent

  • 7.1. Introduction
  • 7.2. Anopheles Species
  • 7.3. Plasmodium Falciparum
  • 7.4. Plasmodium Vivax

8. Malaria Vaccine Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Community Centers
  • 8.4. Hospitals

9. Americas Malaria Vaccine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Malaria Vaccine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Malaria Vaccine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. MALARIA VACCINE MARKET RESEARCH PROCESS
  • FIGURE 2. MALARIA VACCINE MARKET SIZE, 2022 VS 2030
  • FIGURE 3. MALARIA VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. MALARIA VACCINE MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. MALARIA VACCINE MARKET SIZE, BY AGENT, 2022 VS 2030 (%)
  • FIGURE 6. MALARIA VACCINE MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. MALARIA VACCINE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. MALARIA VACCINE MARKET DYNAMICS
  • FIGURE 9. MALARIA VACCINE MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. MALARIA VACCINE MARKET SIZE, BY AGENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. MALARIA VACCINE MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES MALARIA VACCINE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. MALARIA VACCINE MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. MALARIA VACCINE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. MALARIA VACCINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. MALARIA VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. MALARIA VACCINE MARKET SIZE, BY ERYTHROCYTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. MALARIA VACCINE MARKET SIZE, BY MULTI-ANTIGEN VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. MALARIA VACCINE MARKET SIZE, BY PRE-ERYTHROCYTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 9. MALARIA VACCINE MARKET SIZE, BY ANOPHELES SPECIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. MALARIA VACCINE MARKET SIZE, BY PLASMODIUM FALCIPARUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. MALARIA VACCINE MARKET SIZE, BY PLASMODIUM VIVAX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. MALARIA VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. MALARIA VACCINE MARKET SIZE, BY COMMUNITY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. MALARIA VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES MALARIA VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. MALARIA VACCINE MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 144. MALARIA VACCINE MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 145. MALARIA VACCINE MARKET LICENSE & PRICING